CHO Plus Obtains U.S. Patent for Improved Production of Proteins Using Engineered Yeast Cells
Cell Engineering Technology Will Increase Recombinant Protein Production for Food Ingredients, Industrial Enzymes, and Other Products
SOUTH SAN FRANCISCO, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) — CHO Plus, Inc. (www.CHO-Plus.com), a leading developer of biopharmaceutical manufacturing technology, announced that U.S. Patent No. 12,404,502 has been issued by the United States Patent and Trademark Office. The patent covers a technology for fusing yeast together to make hybrid cells that produce more recombinant protein per cell. After fusion, the hybrid cells are sorted for high levels of endoplasmic reticulum, subcellular machinery involved in protein production. The patent protects the technology both as a process for obtaining such cells, and as a composition of matter.
